PG
Procter & Gamble Health Limited
PGHL.NS · NSE
₹5,400.00 -0.47% (-₹25.50)
1M -8.77%
Market Cap ₹90.2B
P/E Ratio 35.92x
Div. Yield -
ROE 45.55%
Bulios Fair Price
₹4,223
21.8% downside
Trenutna cena
₹5,400
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica PGHL.NS trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
5/9Valuation
13 /100
Expensive EV/EBITDA 24.42x
P/S 7.41x
P/B 16.80x
Growth
44 /100
Stable Rev. growth 3.01%
FCF growth 8.33%
Book val. growth 4.50%
Profitability
95 /100
Strong Net margin 20.62%
Op. margin 51.98%
FCF margin 13.73%
Quality
100 /100
Excellent ROE 45.55%
ROA 31.63%
Asset turnover 1.53x
Debt
100 /100
Low Current ratio 2.44x
Int. coverage 598.43x
Net debt/EBITDA -0.50x
Stability
71 /100
Stable Rev. volatility 8.64%
EPS volatility 20.00%
Profitable years 6
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o PGHL.NS
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Milind Vasant Thatte
Employees
1,336
Headquarters
Mumbai
Prihajajoči dogodki
02 DEC.
Earnings
Upcoming earnings report